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The dopamine function in the brain involves structures that 
are related to reward, motivation, judgment, the experience 
of pleasure, motor function, and inhibitory control of 
behavior. These structures maintain the brain functioning..  
Acute effects of methamphetamine intake produce 
euphoria, due to rapid dopamine release in reward regions 
that are stimulated. Furthermore, repeated 
methamphetamine use can lead to drug addiction, with 
chronic effects that produce important changes in brain 
circuits in which dopamine is involved. This produces 
psychotic symptoms, similar to those produced in 
schizophrenia. Therefore, understanding interactions 
between neurotransmitter systems and their relationship 
with symptoms will be an important step towards building a 
coherent hypothesis for schizophrenia pathogenesis. 
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Disturbances in these pathways produce changes 
that are linked to drug addiction.  
Figure 2. Methamphetamine action mechanism 
Methamphetamine (blue triangles) enters the presynaptic neuron, 
replacing the dopamine that is in the cells or its vesicles. Then, it 
substitutes for dopamine (green dots) in  the dopamine transporter (DAT), 
functioning as a substrate. In this way, the DAT endogenous function is 
reverted, resulting in the release of dopamine from its vesicles. This 
stimulates the dopamine receptor (DR) in the postsynaptic neuron.  
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Figure 5.  Detailed dopaminergic pathways 
Different colors represent the diverse dopamine projections in circuits where it is involved. The nigrostriaral pathway (red) is subdivided in a direct and an indirect pathway that send respectively activating and 
inhibitory signals to SNr/Gpi, driven by dopamine release. The mesolimbic pathway (green) sends inhibitory signals to SNr/GPi by GABA projections. Cortical feedback is also important in the regulation of 
processes.  
PFC: prefrontal cortex; VTA: ventral tegmental area; SNc: substantia nigra pars compacta; NAcc: nucleus accumbens; GPe: globus pallidus externa; STN: subthalamic nucleus; SNr: substantia nigra reticulata; 
GPi: globus pallidus interna. D1,D2: dopamine receptors. The purple arrow indicates the mesocortical pathway. Blue discontinued  and continued arrows correspond to the effect of meth action in the system.  
 
Figure 6. Disruption of dopaminergic 
pathways in schizophrenia 
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COMMON EFFECTS 
Figure 1. Methamphetamine chemical 
structure 
Monoamine (lipophilic compound). 
 
Figure 3. Dopaminergic pathways in brain 
The nigrostriatal pathway (red) consists in dopamine release 
from the substantia nigra pars compacta (SNc) to the striatum. 
The mesolimbic pathway (green) includes projections from the 
ventral tegmental area (VTA) to the nucleus accumbens (Nacc). 
In the mesocortical pathway (purple) dopamine release is from 
the VTA to the  prefrontal cortex (PFC). 
Dopamine also modulates other structures’ functioning , like 
the hippocampus, the amygdala, and the dorsal striatum, 
related to memory, conditioning, and habit formation.  
SCHIZOPHRENIA 
Central physiopathology of 
schizophrenia is defined by 
the psychotic element 
driven by increased  ability 
of dopamine release.  
Methamphetamine acts as an agonist of different monoamine 
receptors, binding to its membrane-bound transporters. It 
increases the amount of neurotransmitters in the brain (Figure 
2). The dopamine neurotransmitter is the most important in 
this process.  
In this way, the increased dopamine signals due to 
methamphetamine action, stimulate the three main 
pathways in which it is involved.  
To exert its function, methamphetamine interferes with the 
three main dopaminergic brain pathways (Figure 3), located 
in the cortex and the basal ganglia. These carry out diverse 
functions related to the adequate brain functioning.  
Methamphetamine (also known as meth or crystal)  is a 
potent amphetamine-type stimulant drug that interacts with 
the dopaminergic brain system, producing an 
overactivation, and exerting significant excitation on the 
central nervous system. 
The methamphetamine effects on 
dopaminergic pathways are primarily 
mediated by the notable increase of 
dopamine levels in the brain involved circuits. 
This finally produces an inhibition increase of 
SNr/GPi from the three paths, leading to an 
increase of thalamocortical signals. The result 
is a dopamine increase in the striatum and a 
glutamate excess release in the cortex.  
Due to meth presence, dopamine is released 
from the mesolimbic and the mesocortical 
pathways and it is increased in the striatum 
by the nigrostriatal path.  
The meth interference with normal functioning 
of the dopaminergic system, produces a 
variety of effects that involve changes in 
behavior and cognition.  
Beyond dopamine, cortical GABAergic 
interneurons are also important to maintain 
the signal tone, providing correct cognitive 
functioning in the brain.  
Dopamine, glutamate, and GABA perform an 
important role in synaptic plasticity 
modulation, also related to drug addiction. 
METH 
To define drug addiction, chronic methamphetamine intake is 
necessary. Then, neurochemical changes and alterations in the 
brain circuits are produced, predominantly in the striatum.  
Due to better ability of dopamine release in the Nacc and the dorsal 
striatum, there is also an increase of glutamate levels. Both factors 
result in consequent brain alterations. 
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The main comparison point between methamphetamine effects 
and those produced in schizophrenia, is the dopamine system 
alteration, resulting in a cortical and subcortical function 
imbalance.   
 
 
 
 
 
 
 
 
 
 
Repeated meth use involves psychotic effects that could constitute 
a manner to reflect the same symptoms and cognitive deficits 
seen in schizophrenia. 
 
Figure 7. Particularities. Different brain disturbances are 
observed in both types of patients affected by 
methamphetamine effects or schizophrenia.   
Methamphetamine abuse induces a hyperdopaminergic state by altering the different brain pathways where dopamine is involved. 
Chronic methamphetamine abuse triggers the appearance of psychotic symptoms that can be associated with typical psychosis 
developed in schizophrenia.  
The effects of methamphetamine intake and schizophrenia share similar biological mechanisms that allow the establishment of a 
coherent hypothesis to understand how schizophrenia is developed, by studying neurochemical and general changes in the brain.  
Representation models of the dopaminergic and the GABA systems dysfunction, may help to unify the understanding of 
schizophrenia’s physiopathogenesis. This is the reason why the development of drug models may serve as an important source in this 
area of study.  
The involved changes in behavior and cognition by methamphetamine effects provide a promising approach for studying many aspects 
of schizophrenia.  
The utility of these models cannot only help to understand dysfunctional pathways that lead to psychopathology, but it can also allow 
the prediction of therapeutic efficacy for the treatment of these types of alterations, and which types of compounds may be developed. 
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After meth exposure, persistent adaptive changes are 
produced in those brain regions that modulate mechanisms 
involved in drug addiction.  
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